MetaADEDB 2.0 @ LMMD
dicyclomine, doxylamine, pyridoxine drug combination
(ZUFQODAHGAHPFQ-UHFFFAOYSA-N)
Structure
SMILES
OCc1c(CO)cnc(c1O)C.Cl
Molecular Formula:
C8H12ClNO3
Molecular Weight:
205.639
Log P:
0.8822
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
4
TPSA:
73.58
CAS Number(s):
58-56-0
Synonym(s)
1.
dicyclomine, doxylamine, pyridoxine drug combination
2.
Debendox
3.
Diclectin
4.
Diclegis
5.
bendectin
6.
dicyclomine - doxylamine - pyridoxine
7.
doxylamine succinate - pyridoxine hydrochloride
8.
doxylamine succinate, pyridoxine hydrochloride drug combination
9.
doxylamine, pyridoxine drug combination
External Link(s)
MeSHD011736
C004454
PubChem Compound88396073
517312
145754945
6019
51064122
ChEBI30961
CHEMBLCHEMBL1200756
KEGGdr:D02179
Therapeutic Target DatabaseD07MUN
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug exposure during pregnancyFAERS: 3US FAERS
2AsthmaFAERS: 1US FAERS
3Brain stem syndromeFAERS: 1US FAERS
4BronchiectasisFAERS: 1US FAERS
5Congenital vitreous anomalyFAERS: 1US FAERS
6DisorientationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
7DizzinessFAERS: 1US FAERS
8Electroencephalogram abnormalFAERS: 1US FAERS
9HeadacheFAERS: 1US FAERS
10PalpitationsFAERS: 1US FAERS
11Paradoxical drug reactionFAERS: 1US FAERS
12Polyneuropathy chronicFAERS: 1US FAERS
13SomnolenceFAERS: 1US FAERS
14StuporFAERS: 1US FAERS
15Visual disturbanceFAERS: 1US FAERS
16VitritisFAERS: 1US FAERS
17nervous system disorderFAERS: 1US FAERS
18CataractCanada Vigilance: 1Canada Vigilance
19Cerebral PalsyCanada Vigilance: 1Canada Vigilance
20Congenital brain damageCanada Vigilance: 1Canada Vigilance
21Exfoliative rashCanada Vigilance: 1Canada Vigilance
22Intellectual DisabilityCanada Vigilance: 2Canada Vigilance
23PruritusCanada Vigilance: 1Canada Vigilance
24SynostosisCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.